You have successfully logged out.

Contact

March 31, 2021

B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc., and Infraredx, a Nipro Company, Announce Strategic U.S. Collaboration to Execute the IDE Clinical Trial for the SeQuent® Please ReX™ Drug Coated PTCA Balloon Catheter

Following Receipt of FDA Breakthrough Device Designation, Market Leading Global Organizations Strengthen their Cooperation to Navigate U.S. Regulatory Pathway

References

  1. Moussa ID et al. JACC. 2020; 76(13): 1522-1531.
  2. Scheller B et al. JACC. 2020 ; 75(9): 1017-1028.